Carisma Therapeutics Inc. (NASDAQ: CARM)
$1.31
+0.0500 ( +3.97% ) 419.1K
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Market Data
Open
$1.31
Previous close
$1.26
Volume
419.1K
Market cap
$54.01M
Day range
$1.25 - $1.38
52 week range
$0.99 - $9.77
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Apr 29, 2024 |
8-k | 8K-related | 23 | Apr 10, 2024 |
10-k | Annual reports | 81 | Apr 01, 2024 |
4 | Insider transactions | 1 | Apr 01, 2024 |
3 | Insider transactions | 1 | Apr 01, 2024 |
8-k | 8K-related | 15 | Apr 01, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
8-k | 8K-related | 14 | Nov 09, 2023 |